Mycophenolate mofetil CAS 128794-94-5

CAS: 128794-94-5
Purity: 99%
Molecular Formula: C23H31NO7
Molecular Weight: 433.49
EINECS: /
Storage Period: 2 year

Synonyms: 2-morpholinoethyl(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; 2-morpholinoethyl6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-m; (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoicacid2-morpholin-4-ylethylester; Linfonex; 2-Morpholinoethyl(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; (E)-2-Morpholinoethyl6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-m; 2-morpholin-4-ylethyl(e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-isobenzofuran-5-yl)-4-methyl-hex-4-enoate

    Get a Quote Now!

    We are happy to provide a quotation for your reference at the earliest possible time. You're also welcome to use the live chat on our website for a quick response.

    What is Mycophenolate mofetil CAS 128794-94-5?

    Mycophenolate mofetil is a precursor of active mycophenolic acid (MPA), an immunosuppressive component extracted from the culture fluid of Penicillium. It is an inhibitor of inosine mononucleotide dehydrogenase (IMPDH), which is necessary for the synthesis of guanine nucleotides, especially for the classical synthesis of guanine nucleotides required by lymphocytes.

    Specification

    ITEM STANDARD
    Appearance White crystalline powder
    Purity 99%MIN
    Moisture ≤0.5%
    Total number of oxygen bacteria ≤100 CFU/g

    Application

    Mycophenolate mofetil used in organ transplantation and can also be used to treat autoimmune myasthenia gravis.

    Packaging

    25KG/DRUM

    Mycophenolate mofetil CAS 128794-94-5-Pack-2

      Get a Quote Now!

      We are happy to provide a quotation for your reference at the earliest possible time. You're also welcome to use the live chat on our website for a quick response.

      You may also like